New Labeling Rule Will Require Rx Warnings To Appear At Beginning Of DTC Ads
This article was originally published in The Pink Sheet Daily
Executive Summary
The proposed physician labeling rule will by published by the end of November, FDA Acting Commissioner Crawford says. The rule is designed to provide more useful information to physicians and patients.
You may also be interested in...
Rx Labeling Final Rule Largely In Line With Draft Version
New labeling format will apply initially to recently approved drugs and products receiving approval for new uses, agency says.
Rx Labeling Final Rule Largely In Line With Draft Version
New labeling format will apply initially to recently approved drugs and products receiving approval for new uses, agency says.
FDA Physician Labeling Rule Withdrawn From OMB
Final rule has drawn opposition from industry, especially the addition of a "highlights" section. FDA is proposing staggered implementation to lower the costs of the labeling redesign. Rule would also affect DTC ads. Office of Management & Budget received the reg in January.